GRIK1
Glutamate receptor ionotropic, kainate 1
Also known as: GluK1, GLUR5, GRIK1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P39086
- Gene
- GRIK1
- Ensembl
- ENSG00000171189
- Chromosome
- 21
- Canonical length
- 918 aa
- Protein class
- FDA approved drug targets, Predicted membrane proteins
- Subcellular location
- Vesicles,Plasma membrane
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. This gene product belongs to the kainate family of glutamate receptors, which are composed of four subunits and function as ligand-activated ion channels. The subunit encoded by this gene is subject to RNA editing (CAG->CGG; Q->R) within the second transmembrane domain, which is thought to alter the properties of ion flow. Alternative splicing, resulting in transcript variants encoding different isoforms, has been noted for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
918 residues, UniProt reviewed canonical sequence.
>P39086|GRIK1
1 MEHGTLLAQP GLWTRDTSWA LLYFLCYILP QTAPQVLRIG GIFETVENEP VNVEELAFKF
61 AVTSINRNRT LMPNTTLTYD IQRINLFDSF EASRRACDQL ALGVAALFGP SHSSSVSAVQ
121 SICNALEVPH IQTRWKHPSV DNKDLFYINL YPDYAAISRA ILDLVLYYNW KTVTVVYEDS
181 TGLIRLQELI KAPSRYNIKI KIRQLPSGNK DAKPLLKEMK KGKEFYVIFD CSHETAAEIL
241 KQILFMGMMT EYYHYFFTTL DLFALDLELY RYSGVNMTGF RLLNIDNPHV SSIIEKWSME
301 RLQAPPRPET GLLDGMMTTE AALMYDAVYM VAIASHRASQ LTVSSLQCHR HKPWRLGPRF
361 MNLIKEARWD GLTGHITFNK TNGLRKDFDL DIISLKEEGT EKAAGEVSKH LYKVWKKIGI
421 WNSNSGLNMT DSNKDKSSNI TDSLANRTLI VTTILEEPYV MYRKSDKPLY GNDRFEGYCL
481 DLLKELSNIL GFIYDVKLVP DGKYGAQNDK GEWNGMVKEL IDHRADLAVA PLTITYVREK
541 VIDFSKPFMT LGISILYRKP NGTNPGVFSF LNPLSPDIWM YVLLACLGVS CVLFVIARFT
601 PYEWYNPHPC NPDSDVVENN FTLLNSFWFG VGALMQQGSE LMPKALSTRI VGGIWWFFTL
661 IIISSYTANL AAFLTVERME SPIDSADDLA KQTKIEYGAV RDGSTMTFFK KSKISTYEKM
721 WAFMSSRQQT ALVRNSDEGI QRVLTTDYAL LMESTSIEYV TQRNCNLTQI GGLIDSKGYG
781 VGTPIGSPYR DKITIAILQL QEEGKLHMMK EKWWRGNGCP EEDNKEASAL GVENIGGIFI
841 VLAAGLVLSV FVAIGEFIYK SRKNNDIEQA FCFFYGLQCK QTHPTNSTSG TTLSTDLECG
901 KLIREERGIR KQSSVHTVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GRIK1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 36 nTPM
Expression across tissuesHPA
Tissue
- retina: 36 nTPM
- adrenal gland: 12 nTPM
- hypothalamus: 11 nTPM
- cerebral cortex: 8.6 nTPM
- amygdala: 7.9 nTPM
- hippocampal formation: 7.5 nTPM
Single-cell type
- retinal bipolar cells: 2,906 nCPM
- brain inhibitory neurons: 1,599 nCPM
- oligodendrocyte progenitor cells: 1,553 nCPM
- adrenal medulla cells: 1,298 nCPM
- other brain neurons: 227 nCPM
- brain excitatory neurons: 186 nCPM
Immune cell
- neutrophil: 0.2 nTPM
- classical monocyte: 0.1 nTPM
- eosinophil: 0.1 nTPM
- intermediate monocyte: 0.1 nTPM
- basophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- pons: 73 nTPM
- medulla oblongata: 36 nTPM
- hypothalamus: 32 nTPM
- midbrain: 30 nTPM
- thalamus: 26 nTPM
- hippocampal formation: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.72
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.11
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- central nervous system development
- chemical synaptic transmission
- glutamate receptor signaling pathway
- modulation of chemical synaptic transmission
- nervous system development
- regulation of synaptic transmission, glutamatergic
- synaptic transmission, glutamatergic
Molecular functions
- glutamate-gated calcium ion channel activity
- glutamate-gated receptor activity
- kainate selective glutamate receptor activity
- transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ionotropic glutamate receptor, C-terminal
- Ionotropic glutamate receptor, metazoa
- Receptor, ligand binding region
- Ionotropic glutamate receptor
- Ionotropic glutamate receptor, L-glutamate and glycine-binding domain
- Periplasmic binding protein-like I
- Ligand-gated ion channel
- Receptor family ligand binding region
- Ligated ion channel L-glutamate- and glycine-binding site
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GRIK1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GRIK1 as an antibody target. Whether an autoantibody or antibody against GRIK1 could matter depends on whether native GRIK1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GRIK1 is annotated at the cell surface, where native GRIK1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GRIK1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...